Gustavo A. Rosario Benitez

Array ( [id] => 8293978 [patent_doc_number] => 08221760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Methods of treatment using human anti-IL-23 antibodies' [patent_app_type] => utility [patent_app_number] => 13/173090 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 39395 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8820869 [patent_doc_number] => 20130121914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'TREATMENT DRUG FOR AUTOIMMUNE DISEASES AND ALLERGIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/701408 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17632 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529017 [patent_doc_number] => 09255145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Therapeutic agent for chronic arthritides diseases of childhood-related diseases' [patent_app_type] => utility [patent_app_number] => 13/064953 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13064953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560843 [patent_doc_number] => 20110274675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Therapeutically Useful Molecules' [patent_app_type] => utility [patent_app_number] => 13/090845 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6032 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274675.pdf [firstpage_image] =>[orig_patent_app_number] => 13090845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669480 [patent_doc_number] => 20110318749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'METHOD FOR IDENTIFYING REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 13/087910 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 20837 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13087910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656444 [patent_doc_number] => 20110305713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 13/086090 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21880 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305713.pdf [firstpage_image] =>[orig_patent_app_number] => 13086090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662280 [patent_doc_number] => 20110311549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION' [patent_app_type] => utility [patent_app_number] => 13/083441 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 95079 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311549.pdf [firstpage_image] =>[orig_patent_app_number] => 13083441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741103 [patent_doc_number] => 08106177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Nucleic acids encoding human anti-IL-23 antibodies' [patent_app_type] => utility [patent_app_number] => 13/079457 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 39373 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106177.pdf [firstpage_image] =>[orig_patent_app_number] => 13079457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697125 [patent_doc_number] => 20110229465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITION FOR TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 13/074357 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7652 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229465.pdf [firstpage_image] =>[orig_patent_app_number] => 13074357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703331 [patent_doc_number] => 08828393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist' [patent_app_type] => utility [patent_app_number] => 13/050601 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 47 [patent_no_of_words] => 13197 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13050601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6089395 [patent_doc_number] => 20110217790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Novel CD3 Epsilon Immunogens And Antibodies' [patent_app_type] => utility [patent_app_number] => 13/039722 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14847 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217790.pdf [firstpage_image] =>[orig_patent_app_number] => 13039722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567411 [patent_doc_number] => 09290569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Anti FGF23 antibody and a pharmaceutical composition comprising the same' [patent_app_type] => utility [patent_app_number] => 13/019557 [patent_app_country] => US [patent_app_date] => 2011-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25606 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13019557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757426 [patent_doc_number] => 20120029172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Humanized GM-CSF antibodies' [patent_app_type] => utility [patent_app_number] => 12/931442 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8483 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029172.pdf [firstpage_image] =>[orig_patent_app_number] => 12931442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000600 [patent_doc_number] => 20110117053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHOD OF MODULATING FIBROBLAST ACCUMULATION OR COLLAGEN DEPOSITION' [patent_app_type] => utility [patent_app_number] => 13/012745 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15202 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117053.pdf [firstpage_image] =>[orig_patent_app_number] => 13012745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586359 [patent_doc_number] => 20110280869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS OF PREVENTING OR TREATING INFLAMMATORY OR AUTOIMMUNE DISORDERS BY ADMINISTERING CD2 ANTAGONISTS IN COMBINATION WITH OTHER PROPHYLACTIC OR THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/010074 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80807 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280869.pdf [firstpage_image] =>[orig_patent_app_number] => 13010074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650877 [patent_doc_number] => 20110300146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTI-CMET ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/008836 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 44074 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300146.pdf [firstpage_image] =>[orig_patent_app_number] => 13008836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908978 [patent_doc_number] => 08481037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Recombinant IL-9 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/007211 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 28 [patent_no_of_words] => 103096 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13007211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101685 [patent_doc_number] => 20110165177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Methods of Modulating Immunity' [patent_app_type] => utility [patent_app_number] => 12/982390 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19237 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165177.pdf [firstpage_image] =>[orig_patent_app_number] => 12982390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9551711 [patent_doc_number] => 08758757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)' [patent_app_type] => utility [patent_app_number] => 12/972813 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 38 [patent_no_of_words] => 20806 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12972813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969069 [patent_doc_number] => 20110150891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Methods of Treating Interstitial Cystitis' [patent_app_type] => utility [patent_app_number] => 12/969923 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12573 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150891.pdf [firstpage_image] =>[orig_patent_app_number] => 12969923 [rel_patent_id] =>[rel_patent_doc_number] =>)